TY - JOUR
T1 - Self-Medication of ADHD Symptoms
T2 - Does Caffeine Have a Role?
AU - Ágoston, Csilla
AU - Urbán, R. bert
AU - Horváth, Zsolt
AU - van den Brink, Wim
AU - Demetrovics, Zsolt
N1 - Funding Information: This study was supported by the Hungarian National Research, Development and Innovation Office (Grant Numbers: KKP126835, K131635). Zsolt Horváth was supported by the ÚNKP-21-4 New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund. Publisher Copyright: Copyright © 2022 Ágoston, Urbán, Horváth, van den Brink and Demetrovics.
PY - 2022/2/3
Y1 - 2022/2/3
N2 - Objective: Stimulants are the most effective treatment for Attention Deficit/ Hyperactivity disorder (ADHD). In addition, studies have shown that nicotine dependence in patients with ADHD is probably best explained by self-medication. The question is whether this is also true for caffeine use and caffeine dependence. The aim of our study was, therefore, to examine the relationship of ADHD symptoms, caffeine consumption, caffeine use disorder (CUD) and well-being. We hypothesized that those who have more ADHD symptoms and regularly consume caffeine have higher psychological well-being than those who have more ADHD symptoms, but do not consume caffeine. Methods: A general population sample (N = 2,259, 70.5% male, mean age 34.0) filled out the 10-item Caffeine Use Disorder Questionnaire (CUDQ), the Adult ADHD Self-report Scale (ASRS) and the WHO-5 Well-Being Index (WHO-5) and were asked about their caffeine consumption habits in an online survey. Results: There were no associations between ADHD and coffee, tea, energy drink or cola consumption or daily caffeine consumption. However, the results of the path analysis showed that the level of ADHD symptoms was positively associated with the level of CUD (β = 0.350) and negatively with the WHO-5 (β = −0.259). Conclusions: Caffeine consumption was not associated with ADHD symptom severity and thus not likely to represent self-medication. On the contrary, caffeine use disorder severity is associated with more ADHD symptoms and both caffeine use disorder and ADHD are associated with lower well-being.
AB - Objective: Stimulants are the most effective treatment for Attention Deficit/ Hyperactivity disorder (ADHD). In addition, studies have shown that nicotine dependence in patients with ADHD is probably best explained by self-medication. The question is whether this is also true for caffeine use and caffeine dependence. The aim of our study was, therefore, to examine the relationship of ADHD symptoms, caffeine consumption, caffeine use disorder (CUD) and well-being. We hypothesized that those who have more ADHD symptoms and regularly consume caffeine have higher psychological well-being than those who have more ADHD symptoms, but do not consume caffeine. Methods: A general population sample (N = 2,259, 70.5% male, mean age 34.0) filled out the 10-item Caffeine Use Disorder Questionnaire (CUDQ), the Adult ADHD Self-report Scale (ASRS) and the WHO-5 Well-Being Index (WHO-5) and were asked about their caffeine consumption habits in an online survey. Results: There were no associations between ADHD and coffee, tea, energy drink or cola consumption or daily caffeine consumption. However, the results of the path analysis showed that the level of ADHD symptoms was positively associated with the level of CUD (β = 0.350) and negatively with the WHO-5 (β = −0.259). Conclusions: Caffeine consumption was not associated with ADHD symptom severity and thus not likely to represent self-medication. On the contrary, caffeine use disorder severity is associated with more ADHD symptoms and both caffeine use disorder and ADHD are associated with lower well-being.
KW - ADHD
KW - caffeine
KW - caffeine use disorder
KW - self-medication
KW - well-being
UR - http://www.scopus.com/inward/record.url?scp=85124886494&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fpsyt.2022.813545
DO - https://doi.org/10.3389/fpsyt.2022.813545
M3 - Article
C2 - 35185656
SN - 1664-0640
VL - 13
JO - Frontiers in psychiatry
JF - Frontiers in psychiatry
M1 - 813545
ER -